Sosei announces progression of SD118 for the treatment of neuropathic pain towards Phase 1 studies
26-Feb-2007 -
Sosei Group Corporation announced that its collaborative project SD118, which is under development for the treatment of neuropathic pain, has successfully completed regulatory pre-clinical studies and will now be progressed into Phase 1 clinical trials.
SD118 is being jointly developed with ...
clinical trials
Japan
neuropathic pain